Phillip P. Chan - Mar 29, 2024 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role: Chief Executive Officer, Director
Signature: /s/ Kathleen P. Bloch attorney-in-fact for Phillip P. Chan
Stock symbol: CTSO
Transactions as of: Mar 29, 2024
Transactions value $: $0
Form type: 4
Date filed: 4/2/2024, 09:30 PM
Previous filing: Dec 15, 2023
Next filing: Apr 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTSO	Stock Option (Right to Buy)	Award		+130K			130K	Mar 29, 2024	Common Stock	130K	$0.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person participated in a voluntary salary reduction for the period from April 1, 2024, to December 31, 2024, and these stock options were granted in connection with the salary reduction. These stock options were issued pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying these stock options will vest fully on January 31, 2025, except as set forth on the corresponding non-qualified stock option agreement and subject to the reporting person's continued service as of the applicable vesting date.

Content

The reporting person participated in a voluntary salary reduction for the period from April 1, 2024, to December 31, 2024, and these stock options were granted in connection with the salary reduction. These stock options were issued pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying these stock options will vest fully on January 31, 2025, except as set forth on the corresponding non-qualified stock option agreement and subject to the reporting person's continued service as of the applicable vesting date.